Offer - Urjas Oil for just ₹ 1 X
Olmesar H Tablet (15) is a commercial drug that is prescribed in the form of Tablet. Olmesar H Tablet (15) also has some secondary and off-label uses. These are listed below.
The optimal dosage of Olmesar H Tablet (15) is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
Olmesar H Tablet (15) also has some side effects, the most common being Upper respiratory tract infection. Apart from the aforementioned side effects, Olmesar H Tablet (15) can also lead to other problems, which have been listed below. Such side effects of Olmesar H Tablet (15) normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
Olmesar H Tablet (15)'s effect during pregnancy is Severe and Mild while nursing. In addition, Olmesar H Tablet (15)'s effects on the liver, heart and kidney are discussed below in the Olmesar H Tablet (15) related warnings section.
Olmesar H Tablet (15) is contraindicated in people with pre-existing medical conditions like Asthma, Allergy, Kidney Disease as it can result in adverse effects. Other conditions have been mentioned below in the Olmesar H Tablet (15) contraindications section.
Additionally, Olmesar H Tablet (15) may also adversely react with other medicines. A complete list of these interactions is given below.
In addition to the above precautions for Olmesar H Tablet (15), it is important to know that it is not safe while driving, and is not habit-forming.
Olmesar H Tablet (15) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Olmesar H Tablet (15) safe for pregnant women?
Olmesar H shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Olmesar H Tablet (15) safe during breastfeeding?
Side effects of Olmesar H on breastfeeding women are very mild.
What is the effect of Olmesar H Tablet (15) on the Kidneys?
Olmesar H has very mild side effects on the kidneys.
What is the effect of Olmesar H Tablet (15) on the Liver?
Side effects of Olmesar H rarely affect the liver.
What is the effect of Olmesar H Tablet (15) on the Heart?
Olmesar H has very mild side effects on the heart.
Olmesar H Tablet (15) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Olmesar H Tablet (15) unless your doctor advises you to do so -
Is this Olmesar H Tablet (15) habit forming or addictive?
Olmesar H Tablet (15) does not cause addiction.
Interaction between Food and Olmesar H Tablet (15)
Some foods when eaten with Olmesar H Tablet (15) can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Olmesar H Tablet (15)
Consult your doctor before consuming alcohol while taking Olmesar H Tablet (15) as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173